The TGF-β Signalling Network in Muscle Development, Adaptation and Disease (original) (raw)

• Acharyya S, Ladner KJ, Nelsen LL et al (2004) Cancer cachexia is regulated by selective targeting of skeletal muscle gene products. J Clin Invest 114:370–378
  Article CAS PubMed PubMed Central Google Scholar
• Acharyya S, Villalta SA, Bakkar N et al (2007) Interplay of IKK/NF-kappa B signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy. J Clin Invest 117:889–901
  Article CAS PubMed PubMed Central Google Scholar
• Akhurst RJ, Hata A (2012) Targeting the TGFbeta signalling pathway in disease. Nat Rev Drug Discov 11:790–811
  Article CAS PubMed PubMed Central Google Scholar
• Allen RE, Boxhorn LK (1987) Inhibition of skeletal muscle satellite cell differentiation by transforming growth factor-beta. J Cell Physiol 133:567–572
  Article CAS PubMed Google Scholar
• Allen DL, Unterman TG (2007) Regulation of myostatin expression and myoblast differentiation by FoxO and SMAD transcription factors. Am J Physiol Cell Physiol 292:C188–C199
  Article CAS PubMed Google Scholar
• Andreetta F, Bernasconi P, Baggi F et al (2006) Immunomodulation of TGF-beta1 in mdx mouse inhibits connective tissue proliferation in diaphragm but increases inflammatory response: Implications for antifibrotic therapy. J Neuroimmunol 175:77–86
  Article CAS PubMed Google Scholar
• Anker SD, Negassa A, Coats AJ et al (2003) Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet 361:1077–1083
  Article CAS PubMed Google Scholar
• Annes JP, Chen Y, Munger JS et al (2004) Integrin alphaVbeta6-mediated activation of latent TGF-beta requires the latent TGF-beta binding protein-1. J Cell Biol 165:723–734
  Article CAS PubMed PubMed Central Google Scholar
• Argadine HM, Hellyer NJ, Mantilla CB et al (2009) The effect of denervation on protein synthesis and degradation in adult rat diaphragm muscle. J Appl Physiol 107:438–444
  Article CAS PubMed PubMed Central Google Scholar
• Assoian RK, Komoriya A, Meyers CA et al (1983) Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. J Biol Chem 258:7155–7160
  CAS PubMed Google Scholar
• Attie KM, Borgstein NG, Yang Y et al (2013) A single ascending-dose study of muscle regulator ACE-031 in healthy volunteers. Muscle Nerve 47:416–423
  Article CAS PubMed Google Scholar
• Baldwin RL, Friess H, Yokoyama M et al (1996) Attenuated ALK5 receptor expression in human pancreatic cancer: correlation with resistance to growth inhibition. Int J Cancer 67:283–288
  Article CAS PubMed Google Scholar
• Baran W, Szepietowski JC, Mazur G et al (2007) TGF-beta(1) gene polymorphism in psoriasis vulgaris. Cytokine 38:8–11
  Article CAS PubMed Google Scholar
• Baumann AP, Ibebunjo C, Grasser WA et al (2003) Myostatin expression in age and denervation-induced skeletal muscle atrophy. J Musculoskelet Neuronal Interact 3:8–16
  CAS PubMed Google Scholar
• Bauskin AR, Brown DA, Kuffner T et al (2006) Role of macrophage inhibitory cytokine-1 in tumorigenesis and diagnosis of cancer. Cancer Res 66:4983–4986
  Article CAS PubMed Google Scholar
• Behan WM, Longman C, Petty RK et al (2003) Muscle fibrillin deficiency in Marfan’s syndrome myopathy. J Neurol Neurosurg Psychiatry 74:633–638
  Article CAS PubMed PubMed Central Google Scholar
• Belville C, Josso N, Picard JY (1999) Persistence of Mullerian derivatives in males. Am J Med Genet 89:218–223
  Article CAS PubMed Google Scholar
• Berg JN, Gallione CJ, Stenzel TT et al (1997) The activin receptor-like kinase 1 gene: genomic structure and mutations in hereditary hemorrhagic telangiectasia type 2. Am J Hum Genet 61:60–67
  Article CAS PubMed PubMed Central Google Scholar
• Bernasconi P, Di Blasi C, Mora M et al (1999) Transforming growth factor-beta 1 and fibrosis in congenital muscular dystrophies. Neuromusc Disord 9:28–33
  Article CAS PubMed Google Scholar
• Blobe GC, Schiemann WP, Lodish HF (2000) Role of transforming growth factor beta in human disease. N Engl J Med 342:1350–1358
  Article CAS PubMed Google Scholar
• Bodine SC, Stitt TN, Gonzalez M et al (2001) Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol 3:1014–1019
  Article CAS PubMed Google Scholar
• Bogdanovich S, Krag TO, Barton ER et al (2002) Functional improvement of dystrophic muscle by myostatin blockade. Nature 420:418–421
  Article CAS PubMed Google Scholar
• Bogdanovich S, Perkins KJ, Krag TO et al (2005) Myostatin propeptide-mediated amelioration of dystrophic pathophysiology. FASEB J 19:543–549
  Article CAS PubMed Google Scholar
• Booth FW, Seider MJ (1979) Early change in skeletal muscle protein synthesis after limb immobilization of rats. J Appl Physiol 47:974–977
  CAS PubMed Google Scholar
• Border WA, Noble NA (1994) Transforming growth factor beta in tissue fibrosis. N Engl J Med 331:1286–1292
  Article CAS PubMed Google Scholar
• Bosaeus I, Daneryd P, Svanberg E et al (2001) Dietary intake and resting energy expenditure in relation to weight loss in unselected cancer patients. Int J Cancer 93:380–383
  Article CAS PubMed Google Scholar
• Bottinger EP, Factor VM, Tsang ML et al (1996) The recombinant proregion of transforming growth factor beta1 (latency-associated peptide) inhibits active transforming growth factor beta1 in transgenic mice. Proc Natl Acad Sci U S A 93:5877–5882
  Article CAS PubMed PubMed Central Google Scholar
• Brown DJ, Kim TB, Petty EM et al (2002) Autosomal dominant stapes ankylosis with broad thumbs and toes, hyperopia, and skeletal anomalies is caused by heterozygous nonsense and frameshift mutations in NOG, the gene encoding noggin. Am J Hum Genet 71:618–624
  Article CAS PubMed PubMed Central Google Scholar
• Brunner AM, Marquardt H, Malacko AR et al (1989) Site-directed mutagenesis of cysteine residues in the pro region of the transforming growth factor beta 1 precursor. Expression and characterization of mutant proteins. J Biol Chem 264:13660–13664
  CAS PubMed Google Scholar
• Buijs JT, Henriquez NV, Van Overveld PG et al (2007) TGF-beta and BMP7 interactions in tumour progression and bone metastasis. Clin Exp Metastasis 24:609–617
  Article CAS PubMed Google Scholar
• Burks TN, Andres-Mateos E, Marx R et al. (2011) Losartan restores skeletal muscle remodeling and protects against disuse atrophy in sarcopenia. Sci Transl Med 3:82ra37
  Google Scholar
• Campbell KP, Kahl SD (1989) Association of dystrophin and an integral membrane glycoprotein. Nature 338:259–262
  Article CAS PubMed Google Scholar
• Carlson ME, Conboy MJ, Hsu M et al (2009) Relative roles of TGF-beta1 and Wnt in the systemic regulation and aging of satellite cell responses. Aging Cell 8:676–689
  Article CAS PubMed PubMed Central Google Scholar
• Chang H, Brown CW, Matzuk MM (2002) Genetic analysis of the mammalian transforming growth factor-beta superfamily. Endocr Rev 23:787–823
  Article CAS PubMed Google Scholar
• Cheifetz S, Hernandez H, Laiho M et al (1990) Distinct transforming growth factor-beta (TGF-beta) receptor subsets as determinants of cellular responsiveness to three TGF-beta isoforms. J Biol Chem 265:20533–20538
  CAS PubMed Google Scholar
• Chen YW, Nagaraju K, Bakay M et al (2005) Early onset of inflammation and later involvement of TGF beta in Duchenne muscular dystrophy. Neurology 65:826–834
  Article CAS PubMed Google Scholar
• Chen H, Brady Ridgway J, Sai T et al (2013) Context-dependent signaling defines roles of BMP9 and BMP10 in embryonic and postnatal development. Proc Natl Acad Sci U S A 110:11887–11892
  Article CAS PubMed PubMed Central Google Scholar
• Chen JL, Walton KL, Winbanks CE et al (2014) Elevated expression of activins promotes muscle wasting and cachexia. FASEB J 28:1711–1723
  Article CAS PubMed Google Scholar
• Chen JL, Walton KL, Al-Musawi SL et al (2015) Development of novel activin-targeted therapeutics. Mol Ther 23:434–444
  Article CAS PubMed PubMed Central Google Scholar
• Chiu CS, Peekhaus N, Weber H et al (2013) Increased muscle force production and bone mineral density in ActRIIB-Fc-treated mature rodents. J Gerontol A Biol Sci Med Sci 68:1181–1192
  Article CAS PubMed Google Scholar
• Ciciliot S, Rossi AC, Dyar KA et al (2013) Muscle type and fiber type specificity in muscle wasting. Int J Biochem Cell Biol 45:2191–2199
  Article CAS PubMed Google Scholar
• Clement JH, Raida M, Sanger J et al (2005) Bone morphogenetic protein 2 (BMP-2) induces in vitro invasion and in vivo hormone independent growth of breast carcinoma cells. Int J Oncol 27:401–407
  CAS PubMed Google Scholar
• Cohn RD, Campbell KP (2000) Molecular basis of muscular dystrophies. Muscle Nerve 23:1456–1471
  Article CAS PubMed Google Scholar
• Cohn RD, Van Erp C, Habashi JP et al (2007) Angiotensin II type 1 receptor blockade attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic states. Nat Med 13:204–210
  Article CAS PubMed PubMed Central Google Scholar
• Collins-Hooper H, Sartori R, Macharia R et al. (2014) Propeptide-mediated inhibition of myostatin increases muscle mass through inhibiting proteolytic pathways in aged mice. J Gerontol A Biol Sci Med Sci 69(9):1049–1059
  Google Scholar
• Constantin B (2014) Dystrophin complex functions as a scaffold for signalling proteins. Biochim Biophys Acta-Biomembr 1838:635–642
  Article CAS Google Scholar
• Cornelison DD, Olwin BB, Rudnicki MA et al (2000) MyoD(-/-) satellite cells in single-fiber culture are differentiation defective and MRF4 deficient. Dev Biol 224:122–137
  Article CAS PubMed Google Scholar
• Cusella-De Angelis MG, Molinari S, Le Donne A et al (1994) Differential response of embryonic and fetal myoblasts to TGF beta: a possible regulatory mechanism of skeletal muscle histogenesis. Development 120:925–933
  CAS PubMed Google Scholar
• D’abronzo FH, Swearingen B, Klibanski A et al (1999) Mutational analysis of activin/transforming growth factor-beta type I and type II receptor kinases in human pituitary tumors. J Clin Endocrinol Metab 84:1716–1721
  Article PubMed Google Scholar
• Dam TT, Peters KW, Fragala M et al (2014) An evidence-based comparison of operational criteria for the presence of sarcopenia. J Gerontol A Biol Sci Med Sci 69:584–590
  Article PubMed PubMed Central Google Scholar
• De Boer MD, Selby A, Atherton P et al (2007) The temporal responses of protein synthesis, gene expression and cell signalling in human quadriceps muscle and patellar tendon to disuse. J Physiol 585:241–251
  Article PubMed PubMed Central CAS Google Scholar
• De Crescenzo G, Grothe S, Zwaagstra J et al (2001) Real-time monitoring of the interactions of transforming growth factor-beta (TGF-beta) isoforms with latency-associated protein and the ectodomains of the TGF-beta type II and III receptors reveals different kinetic models and stoichiometries of binding. J Biol Chem 276:29632–29643
  Article PubMed Google Scholar
• Dean JC (2007) Marfan syndrome: clinical diagnosis and management. Eur J Hum Genet 15:724–733
  Article CAS PubMed Google Scholar
• Dewys WD (1986) Weight-loss and nutritional abnormalities in cancer-patients – incidence, severity and significance. Clin Oncol 5:251–261
  Google Scholar
• Dietz HC, Cutting GR, Pyeritz RE et al (1991) Marfan-syndrome caused by a recurrent denovo missense mutation in the fibrillin gene. Nature 352:337–339
  Article CAS PubMed Google Scholar
• Dubois CM, Laprise MH, Blanchette F et al (1995) Processing of transforming growth factor beta 1 precursor by human furin convertase. J Biol Chem 270:10618–10624
  Article CAS PubMed Google Scholar
• Engvall E, Wewer UM (2003) The new frontier in muscular dystrophy research: booster genes. FASEB J 17:1579–1584
  Article CAS PubMed Google Scholar
• Eppert K, Scherer SW, Ozcelik H et al (1996) MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 86:543–552
  Article CAS PubMed Google Scholar
• Ervasti JM, Ohlendieck K, Kahl SD et al (1990) Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature 345:315–319
  Article CAS PubMed Google Scholar
• Fearon K, Arends J, Baracos V (2013) Understanding the mechanisms and treatment options in cancer cachexia. Nat Rev Clin Oncol 10:90–99
  Article CAS PubMed Google Scholar
• Franken R, Radonic T, Den Hartog AW et al (2014) The revised role of TGF-beta in aortic aneurysms in Marfan syndrome. Neth Heart J
  Google Scholar
• Gazzerro E, Canalis E (2006) Bone morphogenetic proteins and their antagonists. Rev Endocr Metab Disord 7:51–65
  Article CAS PubMed Google Scholar
• Ge GX, Hopkins DR, Greenspan DS (2006) GDF11 forms a bone morphogenetic protein 1-activated latent complex that can modulate nerve growth factor-induced differentiation of PC12 cells. FASEB J 20:A515
  Google Scholar
• Gentry LE, Nash BW (1990) The pro domain of pre-pro-transforming growth factor beta 1 when independently expressed is a functional binding protein for the mature growth factor. Biochemistry 29:6851–6857
  Article CAS PubMed Google Scholar
• Gentry LE, Lioubin MN, Purchio AF et al (1988) Molecular events in the processing of recombinant type 1 pre-pro-transforming growth factor beta to the mature polypeptide. Mol Cell Biol 8:4162–4168
  Article CAS PubMed PubMed Central Google Scholar
• Glass D, Roubenoff R (2010) Recent advances in the biology and therapy of muscle wasting. Ann N Y Acad Sci 1211:25–36
  Article PubMed Google Scholar
• Glister C, Kemp CF, Knight PG (2004) Bone morphogenetic protein (BMP) ligands and receptors in bovine ovarian follicle cells: actions of BMP-4, -6 and -7 on granulosa cells and differential modulation of Smad-1 phosphorylation by follistatin. Reproduction 127:239–254
  Article CAS PubMed Google Scholar
• Goggins M, Shekher M, Turnacioglu K et al (1998) Genetic alterations of the transforming growth factor beta receptor genes in pancreatic and biliary adenocarcinomas. Cancer Res 58:5329–5332
  CAS PubMed Google Scholar
• Gong Y, Krakow D, Marcelino J et al (1999) Heterozygous mutations in the gene encoding noggin affect human joint morphogenesis. Nat Genet 21:302–304
  Article CAS PubMed Google Scholar
• Gordon KJ, Blobe GC (2008) Role of transforming growth factor-beta superfamily signaling pathways in human disease. Biochim Biophys Acta 1782:197–228
  Article CAS PubMed Google Scholar
• Gosselin LE, Martinez DA (2004) Impact of TNF-alpha blockade on TGF-beta 1 and type I collagen mRNA expression in dystrophic muscle. Muscle Nerve 30:244–246
  Article CAS PubMed Google Scholar
• Gosselin LE, Williams JE, Deering M et al (2004) Localization and early time course of TGF-beta 1 mRNA expression in dystrophic muscle. Muscle Nerve 30:645–653
  Article CAS PubMed Google Scholar
• Grady WM, Myeroff LL, Swinler SE et al (1999) Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers. Cancer Res 59:320–324
  CAS PubMed Google Scholar
• Greenwald J, Groppe J, Gray P et al (2003) The BMP7/ActRII extracellular domain complex provides new insights into the cooperative nature of receptor assembly. Mol Cell 11:605–617
  Article CAS PubMed Google Scholar
• Groenink M, Den Hartog AW, Franken R et al (2013) Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial. Eur Heart J 34:3491–3500
  Article CAS PubMed Google Scholar
• Groppe JC, Shore EM, Kaplan FS (2007) Functional modeling of the ACVR1 (R206H) mutation in FOP. Clin Orthop Relat Res 462:87–92
  Article PubMed Google Scholar
• Habashi JP, Judge DP, Holm TM et al (2006) Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 312:117–121
  Article CAS PubMed PubMed Central Google Scholar
• Hahn SA, Schutte M, Hoque AT et al (1996) DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271:350–353
  Article CAS PubMed Google Scholar
• Halder SK, Beauchamp RD, Datta PK (2005) A specific inhibitor of TGF-beta receptor kinase, SB-431542, as a potent antitumor agent for human cancers. Neoplasia 7:509–521
  Article CAS PubMed PubMed Central Google Scholar
• Hanafusa H, Ninomiya-Tsuji J, Masuyama N et al (1999) Involvement of the p38 mitogen-activated protein kinase pathway in transforming growth factor-beta-induced gene expression. J Biol Chem 274:27161–27167
  Article CAS PubMed Google Scholar
• Harrington AE, Morris-Triggs SA, Ruotolo BT et al (2006) Structural basis for the inhibition of activin signalling by follistatin. EMBO J 25:1035–1045
  Article CAS PubMed PubMed Central Google Scholar
• Harrison CA, Gray PC, Fischer WH et al (2004) An activin mutant with disrupted ALK4 binding blocks signaling via type II receptors. J Biol Chem 279:28036–28044
  Article CAS PubMed Google Scholar
• Harrison CA, Al-Musawi SL, Walton KL (2011) Prodomains regulate the synthesis, extracellular localisation and activity of TGF-beta superfamily ligands. Growth Factors 29:174–186
  Article CAS PubMed Google Scholar
• Hill JJ, Davies MV, Pearson AA et al (2002) The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum. J Biol Chem 277:40735–40741
  Article CAS PubMed Google Scholar
• Hillebrand M, Millot N, Sheikhzadeh S et al (2014) Total serum transforming growth factor-beta 1 is elevated in the entire spectrum of genetic aortic syndromes. Clin Cardiol 37:672–679
  Article PubMed Google Scholar
• Hoffman EP, Brown RH, Kunkel LM (1987) Dystrophin – the protein product of the duchenne muscular-dystrophy locus. Cell 51:919–928
  Article CAS PubMed Google Scholar
• Hollister DW, Godfrey M, Sakai LY et al (1990) Immunohistologic abnormalities of the microfibrillar-fiber system in the Marfan-syndrome. N Engl J Med 323:152–159
  Article CAS PubMed Google Scholar
• Howe JR, Roth S, Ringold JC et al (1998) Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science 280:1086–1088
  Article CAS PubMed Google Scholar
• Howe JR, Bair JL, Sayed MG et al (2001) Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nat Genet 28:184–187
  Article CAS PubMed Google Scholar
• Hribal ML, Nakae J, Kitamura T et al (2003) Regulation of insulin-like growth factor-dependent myoblast differentiation by Foxo forkhead transcription factors. J Cell Biol 162:535–541
  Article CAS PubMed PubMed Central Google Scholar
• Husken-Hindi P, Tsuchida K, Park M et al (1994) Monomeric activin A retains high receptor binding affinity but exhibits low biological activity. J Biol Chem 269:19380–19384
  CAS PubMed Google Scholar
• Ikushima H, Miyazono K (2010) TGFbeta signalling: a complex web in cancer progression. Nat Rev Cancer 10:415–424
  Article CAS PubMed Google Scholar
• Iwasaki S, Miyak M, Hayashi S et al (2013) Effect of myostatin on chemokine expression in regenerating skeletal muscle cells. Cells Tissues Organs 198:66–74
  Article CAS PubMed Google Scholar
• Iwase S, Murakami T, Saito Y et al (2004) Steep elevation of blood interleukin-6 (IL-6) associated only with late stages of cachexia in cancer patients. Eur Cytokine Netw 15:312–316
  CAS PubMed Google Scholar
• Jacobs PA, Hunt PA, Mayer M et al (1981) Duchenne muscular-dystrophy (DMD) in a female with an X-autosome translocation – further evidence that the dmd locus is at Xp21. Am J Hum Genet 33:513–518
  CAS PubMed PubMed Central Google Scholar
• Javelaud D, Mauviel A (2005) Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-beta: implications for carcinogenesis. Oncogene 24:5742–5750
  Article CAS PubMed Google Scholar
• Jespersen J, Kjaer M, Schjerling P (2006) The possible role of myostatin in skeletal muscle atrophy and cachexia. Scand J Med Sci Sports 16:74–82
  Article CAS PubMed Google Scholar
• Jiang CH, Wen YF, Kuroda K et al (2014) Notch signaling deficiency underlies age-dependent depletion of satellite cells in muscular dystrophy. Dis Model Mech 7:997–1004
  Article PubMed PubMed Central CAS Google Scholar
• Jones SW, Hill RJ, Krasney PA et al (2004) Disuse atrophy and exercise rehabilitation in humans profoundly affects the expression of genes associated with the regulation of skeletal muscle mass. FASEB J 18:1025–1027
  CAS PubMed Google Scholar
• Joulia-Ekaza D, Cabello G (2006) Myostatin regulation of muscle development: molecular basis, natural mutations, physiopathological aspects. Exp Cell Res 312:2401–2414
  Article PubMed CAS Google Scholar
• Judge DP, Dietz HC (2005) Marfan’s syndrome. Lancet 366:1965–1976
  Article CAS PubMed PubMed Central Google Scholar
• Jung B, Nougaret S, Conseil M et al (2014) Sepsis is associated with a preferential diaphragmatic atrophy a critically Ill patient study using tridimensional computed tomography. Anesthesiology 120:1182–1191
  Article PubMed Google Scholar
• Kaartinen V, Warburton D (2003) Fibrillin controls TGF-beta activation. Nat Genet 33:331–332
  Article CAS PubMed Google Scholar
• Kinoshita A, Saito T, Tomita H et al (2000) Domain-specific mutations in TGFB1 result in Camurati-Engelmann disease. Nat Genet 26:19–20
  Article CAS PubMed Google Scholar
• Knaus PI, Lindemann D, Decoteau JF et al (1996) A dominant inhibitory mutant of the type II transforming growth factor beta receptor in the malignant progression of a cutaneous T-cell lymphoma. Mol Cell Biol 16:3480–3489
  Article CAS PubMed PubMed Central Google Scholar
• Koenig M, Hoffman EP, Bertelson CJ et al (1987) Complete cloning of the Duchenne muscular-dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 50:509–517
  Article CAS PubMed Google Scholar
• Kollias HD, Mcdermott JC (2008) Transforming growth factor-beta and myostatin signaling in skeletal muscle. J Appl Physiol 104:579–587
  Article CAS PubMed Google Scholar
• Kubota T, Zhang Q, Wrana JL et al (1989) Multiple forms of SppI (secreted phosphoprotein, osteopontin) synthesized by normal and transformed rat bone cell populations: regulation by TGF-beta. Biochem Biophys Res Commun 162:1453–1459
  Article CAS PubMed Google Scholar
• Kuroda K, Nakashima J, Kanao K et al (2007) Interleukin 6 is associated with cachexia in patients with prostate cancer. Urology 69:113–117
  Article PubMed Google Scholar
• La Thangue NB (1996) E2F and the molecular mechanisms of early cell-cycle control. Biochem Soc Trans 24:54–59
  Article CAS PubMed Google Scholar
• Lach-Trifilieff E, Minetti GC, Sheppard K et al (2014) An antibody blocking activin type II receptors induces strong skeletal muscle hypertrophy and protects from atrophy. Mol Cell Biol 34:606–618
  Article PubMed PubMed Central CAS Google Scholar
• Lacro RV, Guey LT, Dietz HC et al. (2013) Characteristics of children and young adults with Marfan syndrome and aortic root dilation in a randomized trial comparing atenolol and Losartan therapy. Am Heart J 165:828–835
  Google Scholar
• Lacro RV, Dietz HC, Sleeper LA et al (2014) Atenolol versus Losartan in children and young adults with Marfan’s syndrome. N Engl J Med 371:2061–2071
  Article PubMed PubMed Central CAS Google Scholar
• Lam EW, La Thangue NB (1994) DP and E2F proteins: coordinating transcription with cell cycle progression. Curr Opin Cell Biol 6:859–866
  Article CAS PubMed Google Scholar
• Lane KB, Machado RD, Pauciulo MW et al (2000) Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension. Nat Genet 26:81–84
  Article CAS PubMed Google Scholar
• Langley B, Thomas M, Bishop A et al (2002) Myostatin inhibits myoblast differentiation by down-regulating MyoD expression. J Biol Chem 277:49831–49840
  Article CAS PubMed Google Scholar
• Laping NJ, Grygielko E, Mathur A et al (2002) Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542. Mol Pharmacol 62:58–64
  Article CAS PubMed Google Scholar
• Laplante M, Sabatini DM (2012) mTOR signaling in growth control and disease. Cell 149:274–293
  Article CAS PubMed PubMed Central Google Scholar
• Lee SJ (2007) Quadrupling muscle mass in mice by targeting TGF-beta signaling pathways. PLoS One 2, e789
  Article PubMed PubMed Central CAS Google Scholar
• Lee SJ (2008) Genetic analysis of the role of proteolysis in the activation of latent myostatin. PLoS One 3, e1628
  Article PubMed PubMed Central CAS Google Scholar
• Lee SJ, Mcpherron AC (2001) Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci U S A 98:9306–9311
  Article CAS PubMed PubMed Central Google Scholar
• Lee SJ, Reed LA, Davies MV et al (2005) Regulation of muscle growth by multiple ligands signaling through activin type II receptors. Proc Natl Acad Sci U S A 102:18117–18122
  Article CAS PubMed PubMed Central Google Scholar
• Leger B, Derave W, De Bock K et al (2008) Human sarcopenia reveals an increase in SOCS-3 and myostatin and a reduced efficiency of akt phosphorylation. Rejuvenation Res 11:163–175
  Article PubMed CAS Google Scholar
• Lehmann K, Seemann P, Stricker S et al (2003) Mutations in bone morphogenetic protein receptor 1B cause brachydactyly type A2. Proc Natl Acad Sci U S A 100:12277–12282
  Article CAS PubMed PubMed Central Google Scholar
• Lehmann K, Seemann P, Silan F et al (2007) A new subtype of brachydactyly type B caused by point mutations in the bone morphogenetic protein antagonist NOGGIN. Am J Hum Genet 81:388–396
  Article CAS PubMed PubMed Central Google Scholar
• Lewis KA, Gray PC, Blount AL et al (2000) Betaglycan binds inhibin and can mediate functional antagonism of activin signalling. Nature 404:411–414
  Article CAS PubMed Google Scholar
• Li B, Khanna A, Sharma V et al (1999) TGF-beta1 DNA polymorphisms, protein levels, and blood pressure. Hypertension 33:271–275
  Article CAS PubMed Google Scholar
• Li Y, Foster W, Deasy BM et al (2004) Transforming growth factor-beta1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle: a key event in muscle fibrogenesis. Am J Pathol 164:1007–1019
  Article CAS PubMed PubMed Central Google Scholar
• Li S, Shimono C, Norioka N et al (2010) Activin A binds to perlecan through its pro-region that has heparin/heparan sulfate binding activity. J Biol Chem 285:36645–36655
  Article CAS PubMed PubMed Central Google Scholar
• Lipina C, Kendall H, Mcpherron AC et al (2010) Mechanisms involved in the enhancement of mammalian target of rapamycin signalling and hypertrophy in skeletal muscle of myostatin-deficient mice. FEBS Lett 584:2403–2408
  Article CAS PubMed PubMed Central Google Scholar
• Liu D, Black BL, Derynck R (2001) TGF-beta inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3. Genes Dev 15:2950–2966
  Article CAS PubMed PubMed Central Google Scholar
• Loeys BL, Chen J, Neptune ER et al (2005) A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet 37:275–281
  Article CAS PubMed Google Scholar
• Lokireddy S, Mcfarlane C, Ge X et al (2011) Myostatin induces degradation of sarcomeric proteins through a Smad3 signaling mechanism during skeletal muscle wasting. Mol Endocrinol 25:1936–1949
  Article CAS PubMed Google Scholar
• Lokireddy S, Wijesoma IW, Bonala S et al (2012) Myostatin is a novel tumoral factor that induces cancer cachexia. Biochem J 446:23–36
  Article CAS PubMed PubMed Central Google Scholar
• Loscalzo J (2001) Genetic clues to the cause of primary pulmonary hypertension. N Engl J Med 345:367–371
  Article CAS PubMed Google Scholar
• Luo K (2003) Negative regulation of BMP signaling by the ski oncoprotein. J Bone Joint Surg Am 85-A(Suppl 3):39–43
  PubMed Google Scholar
• Maehara Y, Kakeji Y, Kabashima A et al (1999) Role of transforming growth factor-beta 1 in invasion and metastasis in gastric carcinoma. J Clin Oncol 17:607–614
  CAS PubMed Google Scholar
• Massague J (1990) The transforming growth factor-beta family. Annu Rev Cell Biol 6:597–641
  Article CAS PubMed Google Scholar
• Massague J (1998) TGF-beta signal transduction. Annu Rev Biochem 67:753–791
  Article CAS PubMed Google Scholar
• Massague J, Gomis RR (2006) The logic of TGFbeta signaling. FEBS Lett 580:2811–2820
  Article CAS PubMed Google Scholar
• Massague J, Cheifetz S, Endo T et al (1986) Type beta transforming growth factor is an inhibitor of myogenic differentiation. Proc Natl Acad Sci U S A 83:8206–8210
  Article CAS PubMed PubMed Central Google Scholar
• Matyas G, Arnold E, Carrel T et al (2006) Identification and in silico analyses of novel TGFBR1 and TGFBR2 mutations in Marfan syndrome-related disorders. Hum Mutat 27:760–769
  Article CAS PubMed Google Scholar
• Matzuk MM, Finegold MJ, Su JG et al (1992) Alpha-inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature 360:313–319
  Article CAS PubMed Google Scholar
• Matzuk MM, Finegold MJ, Mather JP et al (1994) Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice. Proc Natl Acad Sci U S A 91:8817–8821
  Article CAS PubMed PubMed Central Google Scholar
• Mauro A (1961) Satellite cell of skeletal muscle fibers. J Biophys Biochem Cytol 9:493–495
  Google Scholar
• Mcallister KA, Grogg KM, Johnson DW et al (1994) Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 8:345–351
  Article CAS PubMed Google Scholar
• Mccaffrey TA, Du B, Consigli S et al (1997) Genomic instability in the type II TGF-beta1 receptor gene in atherosclerotic and restenotic vascular cells. J Clin Invest 100:2182–2188
  Article CAS PubMed PubMed Central Google Scholar
• Mccroskery S, Thomas M, Maxwell L et al (2003) Myostatin negatively regulates satellite cell activation and self-renewal. J Cell Biol 162:1135–1147
  Article CAS PubMed PubMed Central Google Scholar
• Mcpherron AC, Lawler AM, Lee SJ (1997) Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 387:83–90
  Article CAS PubMed Google Scholar
• Megeney LA, Kablar B, Garrett K et al (1996) MyoD is required for myogenic stem cell function in adult skeletal muscle. Genes Dev 10:1173–1183
  Article CAS PubMed Google Scholar
• Mendell JR, Sahenk Z, Malik V et al (2015) A phase 1/2a follistatin gene therapy trial for Becker muscular dystrophy. Mol Ther 23:192–201
  Article CAS PubMed PubMed Central Google Scholar
• Mondello P, Mian M, Aloisi C et al (2015) Cancer cachexia syndrome: pathogenesis, diagnosis, and new therapeutic options. Nutr Cancer 67:12–26
  Article CAS PubMed Google Scholar
• Morine KJ, Bish LT, Selsby JT et al (2010) Activin IIB receptor blockade attenuates dystrophic pathology in a mouse model of Duchenne muscular dystrophy. Muscle Nerve 42:722–730
  Article CAS PubMed PubMed Central Google Scholar
• Morissette MR, Cook SA, Buranasombati C et al (2009) Myostatin inhibits IGF-I-induced myotube hypertrophy through Akt. Am J Physiol Cell Physiol 297:C1124–C1132
  Article CAS PubMed Google Scholar
• Morley JE, Thomas DR, Wilson MM (2006) Cachexia: pathophysiology and clinical relevance. Am J Clin Nutr 83:735–743
  CAS PubMed Google Scholar
• Moses AG, Maingay J, Sangster K et al (2009) Pro-inflammatory cytokine release by peripheral blood mononuclear cells from patients with advanced pancreatic cancer: relationship to acute phase response and survival. Oncol Rep 21:1091–1095
  CAS PubMed Google Scholar
• Mulder KM (2000) Role of Ras and Mapks in TGFbeta signaling. Cytokine Growth Factor Rev 11:23–35
  Article CAS PubMed Google Scholar
• Murphy KT, Koopman R, Naim T et al (2010) Antibody-directed myostatin inhibition in 21-mo-old mice reveals novel roles for myostatin signaling in skeletal muscle structure and function. FASEB J 24:4433–4442
  Article CAS PubMed Google Scholar
• Murphy KT, Chee A, Gleeson BG et al (2011) Antibody-directed myostatin inhibition enhances muscle mass and function in tumor-bearing mice. Am J Physiol Regul Integr Comp Physiol 301:R716–R726
  Article CAS PubMed Google Scholar
• Myeroff LL, Parsons R, Kim SJ et al (1995) A transforming growth factor beta receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res 55:5545–5547
  CAS PubMed Google Scholar
• Nakamura T, Takio K, Eto Y et al (1990) Activin-binding protein from rat ovary is follistatin. Science 247:836–838
  Article CAS PubMed Google Scholar
• Neptune ER, Frischmeyer PA, Arking DE et al (2003) Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nat Genet 33:407–411
  Article CAS PubMed Google Scholar
• Ng CM, Cheng A, Myers LA et al (2004) TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome. J Clin Invest 114:1586–1592
  Article CAS PubMed PubMed Central Google Scholar
• Oliff A, Defeo-Jones D, Boyer M et al (1987) Tumors secreting human TNF/cachectin induce cachexia in mice. Cell 50:555–563
  Article CAS PubMed Google Scholar
• Olson EN, Sternberg E, Hu JS et al (1986) Regulation of myogenic differentiation by type beta transforming growth factor. J Cell Biol 103:1799–1805
  Article CAS PubMed Google Scholar
• Pannu H, Avidan N, Tran-Fadulu V et al (2006) Genetic basis of thoracic aortic aneurysms and dissections: potential relevance to abdominal aortic aneurysms. Ann N Y Acad Sci 1085:242–255
  Article CAS PubMed Google Scholar
• Pees C, Laccone F, Hagl M et al (2013) Usefulness of Losartan on the size of the ascending aorta in an unselected cohort of children, adolescents, and young adults with Marfan syndrome. Am J Cardiol 112:1477–1483
  Article CAS PubMed Google Scholar
• Philip B, Lu Z, Gao Y (2005) Regulation of GDF-8 signaling by the p38 MAPK. Cell Signal 17:365–375
  Article CAS PubMed Google Scholar
• Pirisi M, Fabris C, Luisi S et al (2000) Evaluation of circulating activin-A as a serum marker of hepatocellular carcinoma. Cancer Detect Prev 24:150–155
  CAS PubMed Google Scholar
• Pistilli EE, Bogdanovich S, Goncalves MD et al (2011) Targeting the activin type IIB receptor to improve muscle mass and function in the mdx mouse model of Duchenne muscular dystrophy. Am J Pathol 178:1287–1297
  Article PubMed PubMed Central Google Scholar
• Puthucheary ZA, Rawal J, Mcphail M et al (2013) Acute skeletal muscle wasting in critical illness. JAMA 310:1591–1600
  Article CAS PubMed Google Scholar
• Rahimi RA, Leof EB (2007) TGF-beta signaling: a tale of two responses. J Cell Biochem 102:593–608
  Article CAS PubMed Google Scholar
• Ramirez F, Dietz HC (2007) Marfan syndrome: from molecular pathogenesis to clinical treatment. Curr Opin Genet Dev 17:252–258
  Article CAS PubMed Google Scholar
• Ramirez F, Rifkin DB (2009) Extracellular microfibrils: contextual platforms for TGFbeta and BMP signaling. Curr Opin Cell Biol 21:616–622
  Article CAS PubMed PubMed Central Google Scholar
• Ramirez F, Carta L, Lee-Arteaga S et al (2008) Fibrillin-rich microfibrils – structural and instructive determinants of mammalian development and physiology. Connect Tissue Res 49:1–6
  Article CAS PubMed Google Scholar
• Reardon KA, Davis J, Kapsa RM et al (2001) Myostatin, insulin-like growth factor-1, and leukemia inhibitory factor mRNAs are upregulated in chronic human disuse muscle atrophy. Muscle Nerve 24:893–899
  Article CAS PubMed Google Scholar
• Reinhardt DP, Ono RN, Sakai LY (1997) Calcium stabilizes fibrillin-1 against proteolytic degradation. J Biol Chem 272:1231–1236
  Article CAS PubMed Google Scholar
• Ribeiro SM, Poczatek M, Schultz-Cherry S et al (1999) The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-beta. J Biol Chem 274:13586–13593
  Article CAS PubMed Google Scholar
• Rifkin DB (2005) Latent transforming growth factor-beta (TGF-beta) binding proteins: orchestrators of TGF-beta availability. J Biol Chem 280:7409–7412
  Article CAS PubMed Google Scholar
• Riggins GJ, Kinzler KW, Vogelstein B et al (1997) Frequency of Smad gene mutations in human cancers. Cancer Res 57:2578–2580
  CAS PubMed Google Scholar
• Rios R, Carneiro I, Arce VM et al (2002) Myostatin is an inhibitor of myogenic differentiation. Am J Physiol Cell Physiol 282:C993–C999
  Article CAS PubMed Google Scholar
• Rodino-Klapac LR, Haidet AM, Kota J et al (2009) Inhibition of myostatin with emphasis on follistatin as a therapy for muscle disease. Muscle Nerve 39:283–296
  Article CAS PubMed PubMed Central Google Scholar
• Roubenoff R (2000) Sarcopenia and its implications for the elderly. Eur J Clin Nutr 54(Suppl 3):S40–S47
  Article PubMed Google Scholar
• Sabatelli P, Gualandi F, Gara SK et al (2012) Expression of collagen VI alpha 5 and alpha 6 chains in human muscle and in Duchenne muscular dystrophy-related muscle fibrosis. Matrix Biol 31:187–196
  Article CAS PubMed PubMed Central Google Scholar
• Salam MT, Gauderman WJ, Mcconnell R et al (2007) Transforming growth factor- 1 C-509 T polymorphism, oxidant stress, and early-onset childhood asthma. Am J Respir Crit Care Med 176:1192–1199
  Article CAS PubMed PubMed Central Google Scholar
• Sartori R, Milan G, Patron M et al (2009) Smad2 and 3 transcription factors control muscle mass in adulthood. Am J Physiol Cell Physiol 296:C1248–C1257
  Article CAS PubMed Google Scholar
• Sartori R, Schirwis E, Blaauw B et al (2013) BMP signaling controls muscle mass. Nat Genet 45:1309–1318
  Article CAS PubMed Google Scholar
• Schneyer AL, Sidis Y, Gulati A et al (2008) Differential antagonism of activin, myostatin and growth and differentiation factor 11 by wild-type and mutant follistatin. Endocrinology 149:4589–4595
  Article CAS PubMed PubMed Central Google Scholar
• Scott HR, Mcmillan DC, Crilly A et al (1996) The relationship between weight loss and interleukin 6 in non-small-cell lung cancer. Br J Cancer 73:1560–1562
  Article CAS PubMed PubMed Central Google Scholar
• Sengle G, Charbonneau NL, Ono RN et al (2008a) Targeting of bone morphogenetic protein growth factor complexes to fibrillin. J Biol Chem 283:13874–13888
  Article CAS PubMed PubMed Central Google Scholar
• Sengle G, Ono RN, Lyons KM et al (2008b) A new model for growth factor activation: type II receptors compete with the prodomain for BMP-7. J Mol Biol 381:1025–1039
  Article CAS PubMed PubMed Central Google Scholar
• Serrano AL, Munoz-Canoves P (2010) Regulation and dysregulation of fibrosis in skeletal muscle. Exp Cell Res 316:3050–3058
  Article CAS PubMed Google Scholar
• Shao CX, Liu M, Wu X et al (2007) Time-dependent expression of myostatin RNA transcript and protein in gastrocnemius muscle of mice after sciatic nerve resection. Microsurgery 27:487–493
  Article PubMed Google Scholar
• Shi Y, Massague J (2003) Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113:685–700
  Article CAS PubMed Google Scholar
• Shi YQ, Katsev S, Cai C et al (2000) BMP signaling is required for heart formation in vertebrates. Dev Biol 224:226–237
  Article CAS PubMed Google Scholar
• Shimasaki S, Moore RK, Otsuka F et al (2004) The bone morphogenetic protein system in mammalian reproduction. Endocr Rev 25:72–101
  Article CAS PubMed Google Scholar
• Shore EM, Xu M, Feldman GJ et al (2006) A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet 38:525–527
  Article CAS PubMed Google Scholar
• Shovlin CL, Hughes JM, Scott J et al (1997) Characterization of endoglin and identification of novel mutations in hereditary hemorrhagic telangiectasia. Am J Hum Genet 61:68–79
  Article CAS PubMed PubMed Central Google Scholar
• Sidis Y, Mukherjee A, Keutmann H et al (2006) Biological activity of follistatin isoforms and follistatin-like-3 is dependent on differential cell surface binding and specificity for activin, myostatin, and bone morphogenetic proteins. Endocrinology 147:3586–3597
  Article CAS PubMed Google Scholar
• Simpson CM, Stanton PG, Walton KL et al (2012) Activation of latent human GDF9 by a single residue change (Gly 391 Arg) in the mature domain. Endocrinology 153:1301–1310
  Article CAS PubMed Google Scholar
• Slayton RL, Williams L, Murray JC et al (2003) Genetic association studies of cleft lip and/or palate with hypodontia outside the cleft region. Cleft Palate Craniofac J 40:274–279
  Article PubMed PubMed Central Google Scholar
• Spurney CF, Sali A, Guerron AD et al (2011) Losartan decreases cardiac muscle fibrosis and improves cardiac function in dystrophin-deficient Mdx mice. J Cardiovasc Pharmacol Ther 16:87–95
  Article CAS PubMed PubMed Central Google Scholar
• Tan BH, Fearon KC (2008) Cachexia: prevalence and impact in medicine. Curr Opin Clin Nutr Metab Care 11:400–407
  Article PubMed Google Scholar
• Tanabe A, Taketani S, Endo-Ichikawa Y et al (2000) Analysis of the candidate genes responsible for non-syndromic cleft lip and palate in Japanese people. Clin Sci 99:105–111
  Article CAS PubMed Google Scholar
• Tang AM, Forrester J, Spiegelman D et al (2002) Weight loss and survival in HIV-positive patients in the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 31:230–236
  Article PubMed Google Scholar
• Ten Dijke P, Arthur HM (2007) Extracellular control of TGFbeta signalling in vascular development and disease. Nat Rev Mol Cell Biol 8:857–869
  Article PubMed CAS Google Scholar
• Thawani JP, Wang AC, Than KD et al (2010) Bone morphogenetic proteins and cancer: review of the literature. Neurosurgery 66:233–246, discussion 246
  Article PubMed Google Scholar
• Theologides A (1979) Cancer cachexia. Cancer 43:2004–2012
  Article CAS PubMed Google Scholar
• Thiagalingam S, Lengauer C, Leach FS et al (1996) Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nat Genet 13:343–346
  Article CAS PubMed Google Scholar
• Thies RS, Chen T, Davies MV et al (2001) GDF-8 propeptide binds to GDF-8 and antagonizes biological activity by inhibiting GDF-8 receptor binding. Growth Factors 18:251–259
  Article CAS PubMed Google Scholar
• Thomas JT, Lin K, Nandedkar M et al (1996) A human chondrodysplasia due to a mutation in a TGF-beta superfamily member. Nat Genet 12:315–317
  Article CAS PubMed Google Scholar
• Thomas JT, Kilpatrick MW, Lin K et al (1997) Disruption of human limb morphogenesis by a dominant negative mutation in CDMP1. Nat Genet 17:58–64
  Article CAS PubMed Google Scholar
• Thomas M, Langley B, Berry C et al (2000) Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation. J Biol Chem 275:40235–40243
  Article CAS PubMed Google Scholar
• Thys M, Schrauwen I, Vanderstraeten K et al (2007) The coding polymorphism T263I in TGF-beta1 is associated with otosclerosis in two independent populations. Hum Mol Genet 16:2021–2030
  Article CAS PubMed Google Scholar
• Tisdale MJ (2002) Cachexia in cancer patients. Nat Rev Cancer 2:862–871
  Article CAS PubMed Google Scholar
• Tisdale MJ (2009) Mechanisms of cancer cachexia. Physiol Rev 89:381–410
  Article CAS PubMed Google Scholar
• Trendelenburg AU, Meyer A, Rohner D et al (2009) Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size. Am J Physiol Cell Physiol 296:C1258–C1270
  Article CAS PubMed Google Scholar
• Tsuchida K (2006) The role of myostatin and bone morphogenetic proteins in muscular disorders. Expert Opin Biol Ther 6:147–154
  Article CAS PubMed Google Scholar
• Tsuchida K, Arai KY, Kuramoto Y et al (2000) Identification and characterization of a novel follistatin-like protein as a binding protein for the TGF-beta family. J Biol Chem 275:40788–40796
  Article CAS PubMed Google Scholar
• Tsuchida K, Nakatani M, Matsuzaki T et al (2004) Novel factors in regulation of activin signaling. Mol Cell Endocrinol 225:1–8
  Article CAS PubMed Google Scholar
• Vakonakis I, Campbell ID (2007) Extracellular matrix: from atomic resolution to ultrastructure. Curr Opin Cell Biol 19:578–583
  Article CAS PubMed Google Scholar
• Vallese D, Negroni E, Duguez S et al (2013) The Rag2(-)Il2rb(-)Dmd(-) mouse: a novel dystrophic and immunodeficient model to assess innovating therapeutic strategies for muscular dystrophies. Mol Ther 21:1950–1957
  Article CAS PubMed PubMed Central Google Scholar
• Villanueva A, Garcia C, Paules AB et al (1998) Disruption of the antiproliferative TGF-beta signaling pathways in human pancreatic cancer cells. Oncogene 17:1969–1978
  Article CAS PubMed Google Scholar
• Visvanathan R, Chapman IM (2009) Undernutrition and anorexia in the older person. Gastroenterol Clin North Am 38:39–409
  Google Scholar
• Wagner KR, Liu X, Chang X et al (2005) Muscle regeneration in the prolonged absence of myostatin. Proc Natl Acad Sci U S A 102:2519–2524
  Article CAS PubMed PubMed Central Google Scholar
• Wall BT, Dirks ML, Snijders T et al (2014) Substantial skeletal muscle loss occurs during only 5 days of disuse. Acta Physiol (Oxf) 210:600–611
  Article CAS Google Scholar
• Walton KL, Makanji Y, Wilce MC et al (2009) A common biosynthetic pathway governs the dimerization and secretion of inhibin and related transforming growth factor beta (TGFbeta) ligands. J Biol Chem 284:9311–9320
  Article CAS PubMed PubMed Central Google Scholar
• Walton KL, Makanji Y, Chen J et al. (2010) Two distinct regions of latency associated peptide coordinate stability of the latent TGF-{beta}1 complex. J Biol Chem 285(22):17029–17037
  Google Scholar
• Watt KI, Jaspers RT, Atherton P et al (2010) SB431542 treatment promotes the hypertrophy of skeletal muscle fibers but decreases specific force. Muscle Nerve 41:624–629
  CAS PubMed Google Scholar
• Wheeler MT, Snyder EC, Patterson MN et al (1999) An E-box within the MHC IIB gene is bound by MyoD and is required for gene expression in fast muscle. Am J Physiol 276:C1069–C1078
  CAS PubMed Google Scholar
• Wigmore SJ, Plester CE, Richardson RA et al (1997) Changes in nutritional status associated with unresectable pancreatic cancer. Br J Cancer 75:106–109
  Article CAS PubMed PubMed Central Google Scholar
• Wildi S, Kleeff J, Maruyama H et al (2001) Overexpression of activin A in stage IV colorectal cancer. Gut 49:409–417
  Article CAS PubMed PubMed Central Google Scholar
• Winbanks CE, Weeks KL, Thomson RE et al (2012) Follistatin-mediated skeletal muscle hypertrophy is regulated by Smad3 and mTOR independently of myostatin. J Cell Biol 197:997–1008
  Article CAS PubMed PubMed Central Google Scholar
• Winbanks CE, Chen JL, Qian H et al (2013) The bone morphogenetic protein axis is a positive regulator of skeletal muscle mass. J Cell Biol 203:345–357
  Article CAS PubMed PubMed Central Google Scholar
• Wolfman NM, Mcpherron AC, Pappano WN et al (2003) Activation of latent myostatin by the BMP-1/tolloid family of metalloproteinases. Proc Natl Acad Sci U S A 100:15842–15846
  Article CAS PubMed PubMed Central Google Scholar
• Wrighton KH, Lin X, Feng XH (2009a) Phospho-control of TGF-beta superfamily signaling. Cell Res 19:8–20
  Article CAS PubMed PubMed Central Google Scholar
• Wrighton KH, Lin X, Yu PB et al (2009b) Transforming growth factor {beta} Can stimulate Smad1 phosphorylation independently of bone morphogenic protein receptors. J Biol Chem 284:9755–9763
  Article CAS PubMed PubMed Central Google Scholar
• Wu MY, Hill CS (2009) Tgf-beta superfamily signaling in embryonic development and homeostasis. Dev Cell 16:329–343
  Article CAS PubMed Google Scholar
• Yaden BC, Wang YX, Wilson JM et al (2014) Inhibition of activin A ameliorates skeletal muscle injury and rescues contractile properties by inducing efficient remodeling in female mice. Am J Pathol 184:1152–1166
  Article CAS PubMed Google Scholar
• Yamada Y, Miyauchi A, Goto J et al (1998) Association of a polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women. J Bone Miner Res 13:1569–1576
  Article CAS PubMed Google Scholar
• Zanotti S, Gibertini S, Mora M (2010) Altered production of extra-cellular matrix components by muscle-derived Duchenne muscular dystrophy fibroblasts before and after TGF-beta 1 treatment. Cell Tissue Res 339:397–410
  Article CAS PubMed Google Scholar
• Zdychova J, Komers R (2005) Emerging role of Akt kinase/protein kinase B signaling in pathophysiology of diabetes and its complications. Physiol Res 54:1–16
  CAS PubMed Google Scholar
• Zhang H, Bradley A (1996) Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development. Development 122:2977–2986
  CAS PubMed Google Scholar
• Zhang DL, Liu M, Ding F et al (2006) Expression of myostatin RNA transcript and protein in gastrocnemius muscle of rats after sciatic nerve resection. J Muscle Res Cell Motil 27:37–44
  Article PubMed CAS Google Scholar
• Zhang P, Li WJ, Liu HJ et al (2014) Dystrophin involved in the susceptibility of slow muscles to hindlimb unloading via concomitant activation of TGF-beta 1/Smad3 signaling and ubiquitin-proteasome degradation in mice. Cell Biochem Biophys 70:1057–1067
  Article CAS PubMed Google Scholar
• Zhao J, Brault JJ, Schild A et al (2007) FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. Cell Metab 6:472–483
  Article CAS PubMed Google Scholar
• Zhou XP, Woodford-Richens K, Lehtonen R et al (2001) Germline mutations in BMPR1A/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromes. Am J Hum Genet 69:704–711
  Article CAS PubMed PubMed Central Google Scholar
• Zhou X, Wang JL, Lu J et al (2010) Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival. Cell 142:531–543
  Article CAS PubMed Google Scholar
• Zhu X, Topouzis S, Liang LF et al (2004) Myostatin signaling through Smad2, Smad3 and Smad4 is regulated by the inhibitory Smad7 by a negative feedback mechanism. Cytokine 26:262–272
  Article CAS PubMed Google Scholar
• Zimmers TA, Davies MV, Koniaris LG et al (2002) Induction of cachexia in mice by systemically administered myostatin. Science 296:1486–1488
  Article CAS PubMed Google Scholar
• Zugmaier G, Paik S, Wilding G et al (1991) Transforming growth factor beta 1 induces cachexia and systemic fibrosis without an antitumor effect in nude mice. Cancer Res 51:3590–3594
  CAS PubMed Google Scholar